Leadership, Planning and Evaluation

3.0 Abstract: Leadership, Planning, and Evaluation The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has a robust program planning and evaluation process, which includes several groups with internal and external expertise. These groups monitor the scientific activities of UMGCCC, evaluate new scientific opportunities, and define future strategic scientific needs of the Cancer Center with regard to personnel, facilities, and technologies. UMGCCC leadership includes a team of highly qualified scientists and administrators who work together to monitor the status of the Cancer Center and move it forward. UMGCCC director Dr. Kevin Cullen meets regularly with Dr. Richard Eckert, UMGCCC deputy director, and the P30 executive committee, which comprises the associate directors and administrative leadership. This group is responsible for establishing scientific priorities for the Cancer Center, including recruitment priorities. It also monitors all the internal and external planning and evaluation functions described in this section. In addition, UMGCCC regularly engages external experts to evaluate and advise UMGCCC leadership on the structure and function of its shared services and research programs. Each shared service and program has been independently evaluated and received formal recommendations. UMGCCC is fortunate to rely on the expertise and counsel of the External Scientific Advisory Committee, which consists of one senior Cancer Center administrator and 10 senior cancer investigators from around the country, all of whom provide a range of expertise in Cancer Center clinical, translational, and population research as well as administration. Program planning and evaluation are critical to the overall function of UMGCCC and its evolution. Numerous changes that have resulted from this process are evident in this grant application and reflect the commitment of UMGCCC to conduct regular, comprehensive evaluations of all its components.